急性缺血性卒中静脉溶栓中国卒中学会科学声明

被引:139
作者
机构
[1] 中国卒中学会科学声明专家组
关键词
卒中; 静脉; 溶栓; 时间窗; 特殊人群; 获益; 风险; 声明;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
1背景目前,急性缺血性卒中(acute ischemic stroke,AIS)最有效的药物治疗仍是超早期内(<4.5 h)给予重组组织型纤溶酶原激活剂(recombinant tissue plasminogen activator,rt-PA)静脉溶栓,因其可显著改善AIS预后,被国内外脑血管病指南一致推荐。2012年12月《中华内科杂志》发表的《重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)》和2014年发表的《中国急性缺血性脑卒中诊治指南2014》对规范我国AIS
引用
收藏
页码:267 / 284
页数:18
相关论文
共 82 条
[1]   中国急性缺血性脑卒中早期血管内介入诊疗指南 [J].
朱武生 ;
刘文华 ;
刘新峰 .
中华神经科杂志, 2015, 48 (05) :356-361
[2]   急性脑梗死六小时以内的静脉溶栓治疗 [J].
国家“九五”攻关课题协作组 .
中华神经科杂志, 2002, (04) :21-24
[3]  
Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients[J] . Siyan Chen,Xia Lu,Wanli Zhang,Zhao Han,Wen Yang,Xuerong Huang,Xiaoping Jin,Zhiming Wang,Haiyan Liang,Weiwen Qiu,Jianhua Cheng,Bei Shao.Journal of Stroke and Cerebrovascular Diseases . 2016
[4]  
Case Report: A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration[J] . Lesley Pahs.Annals of Emergency Medicine . 2015
[5]  
Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis[J] . Tomá? Dorňák,Michal Král,Martin Hazlinger,Roman Herzig,Tomá? Veverka,Stanislav Bu?val,Daniel ?aňák,Jana Zapletalová,Kristyna Antalíková,Petr Kaňovsky.Int J Stroke . 2015 (8)
[6]  
IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry[J] . Michael V. Mazya,Kennedy R. Lees,David Collas,Viiu-Marika Rand,Robert Mikulik,Danilo Toni,Nils Wahlgren,Niaz Ahmed.Neurology . 2015 (24)
[7]  
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . William J. Powers,Colin P. Derdeyn,José Biller,Christopher S. Coffey,Brian L. Hoh,Edward C. Jauch,Karen C. Johnston,S. Claiborne Johnston,Alexander A. Khalessi,Chelsea S. Kidwell,James F. Meschi
[8]   Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke [J].
Wardlaw, Joanna M. ;
von Kummer, Rudiger ;
Carpenter, Trevor ;
Parsons, Mark ;
Lindley, Richard I. ;
Cohen, Geoff ;
Murray, Veronica ;
Kobayashi, Adam ;
Peeters, Andre ;
Chappell, Francesca ;
Sandercock, Peter A. G. .
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (06) :956-968
[9]   Future directions of acute ischaemic stroke therapy [J].
Fisher, Marc ;
Saver, Jeffrey L. .
LANCET NEUROLOGY, 2015, 14 (07) :758-767
[10]  
Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial[J] . Gregory W Albers,Rüdiger von Kummer,Thomas Truelsen,Jens-Kristian S Jensen,Gabriela M Ravn,Bj?rn A Gr?nning,Hugues Chabriat,Ku-Chou Chang,Antonio E Davalos,Gary A Ford,James Grotta,Markku Kaste,Lee H Schwamm,Ashfaq Shuaib.The Lancet Neurology . 2015 (6)